A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04401475 |
|
Recruitment Status :
Recruiting
First Posted : May 26, 2020
Last Update Posted : May 3, 2021
|
Sponsor:
Edesa Biotech Inc.
Collaborator:
JSS Medical Research Inc.
Information provided by (Responsible Party):
Edesa Biotech Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | April 2021 |
| Estimated Study Completion Date : | April 2021 |